Circular-15-of-2022-Safety-measures-for-sodium-valproate-and-the-risk-of-congenital-malformations-in-neonates-and-neurodevelopmental-disorders-in-children-exposed-to-sodium-valproate-during-pregnancy

Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits

Circular 8 of 2022 -Publication of Cancelled Wholesale Dealers’ Permit and Persons’ Licences

Circular 5 of 2022 – Publication of Cancelled Premises and Persons’ Licences.

Circular 3 of 2022 – Clarification of Conditions for Medicines Registration Requirements and Subsequent Expansion of Registration Certificate, Section 15 Format Annexure

Circular 25 of 2022- Notification of issuance of revised registration certificates for variations at re-registration

Circular 24 of 2022- Importation of Medicines

Circular 23 of 2022- Importation of Medicines

Circular 21 of 2022 – Invitation to stakeholders meetings

Circular 20 of 2022 CBD products clarification